Fibrinolysis during cardiac surgery: Release of tissue plasminogenactivator in arterial and coronary sinus blood

European Journal of Cardio-thoracic Surgery

Volumn 8, Issue 6, 1994, Pages 324-330

  Valen, G ^a   Eriksson, E ^b   Risberg, B ^b   Vaage, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardioplegia; Cardiopulmonary bypass; Endothelium; Fibrinolysis; Tissue plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTERY; ARTICLE; BLOOD; CARDIOPULMONARY BYPASS; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY BLOOD VESSEL; FIBRINOLYSIS; HEART ARREST; HEART SURGERY; HUMAN; TIME; VASCULAR ENDOTHELIUM;

AGED; ARTERIES; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; COMPARATIVE STUDY; CORONARY ARTERY BYPASS; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FIBRINOLYSIS; HEART ARREST, INDUCED; HUMAN; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0028320881     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/S1010-7940(05)80093-4     Document Type: Article

References (42)

1. Andersen LW, Baek L, Degn H, Lehd J, Krasnik M, Rasmussen JP (1987) Presence of circulating endotoxins during cardiac operations. J Thorac Cardiovasc Surg 93:115 -119
2. Aoyama T, Yui Y, Takatsu Y, Takahashi M, Murohara Y, Shirotani M, Yasumoto H, Morishita H, Kadota K, Sakaguchi K, Kawai C (1990) The dynamic changes of tissue-type plasminogen activator level and the activity of its inhibitor during coronary vasospasm. Jpn Circ J 54:1139-1146
3. Benthuysen KM van, McMurtry IF, Horwitz LD (1986) Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest 79:265-274
4. Bick RL (1985) Hemostasis defects associated with cardiac surgery, prosthetic devices, and other extracorporeal circuits. Semin Thromb Hemost 11:249 - 280
5. Bolli R, Jeroud MO, Patel BS, DuBose CM, Lai EK, Roberts R, McCay PB (1989) Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci 86:4695-4699
6. Brommer EJP, Brakman P (1991) Developments in fibrinolysis. In: Poller L (ed) Recent advances in blood coagulation 5.Churchill Livingstone, Edinburgh London Melbourne New York Tokyo, pp 17-34
7. Cavarocchi NC, England MD, Schaff HV, Russo P, Orszulak TA, Schnell WA, O’Brien JF, Pluth JR (1986) Oxygen free radical generation during cardiopulmonary bypass: Correlation with complement activation. Circulation 74: 3 130—133
8. Dinerman JL, Mehta JL (1990) Endothelial, platelet and leukocyte interactions in ischemic heart disease: Insights into potential mechanisms and their clinical relevance. J Am Coll Cardiol 16:207-222
9. Emeis JJ (1988) Mechanisms involved in short-term changes in blood levels of t-PA. In: Kluft C (ed) Tissue-type plasminogen activator (t-PA): Physiological and clinical aspects (volume II). CRC Press, Boca Raton, Florida, pp 22-31
10. Forbes CD, Courtney JM (1987) Thrombosis and artificial surfaces. In: Bloom AL, Thomas DP (eds) Haemostasis and thrombosis. Churchill Livingstone, Edinburgh London Melbourne and New York, pp 902-921
11. Fujii S, Lucore CL, Hopkins WE, Billadello JJ, Sobel BE (1990) Induction of synthesis of plasminogen activator inhibitor type- 1 by tissue-type plasminogen activator in human hepatic and endothelial cells. Thromb Haemost 64:412-419
12. Hashimoto K, Pearson PJ, Schaff HV, Cartier R (1991) Endothelial cell dysfunction after ischemic arrest and reperfusion: A possible mechanism of myocardial injury during reflow. J Tho- rac Cardiovasc Surg 102:688-694
13. Jansen NJG, Oeveren W van, Brouk L v d, O Oudemans-van Straa- ten HM, Stoutenbeek CP, Chang Noek Joen M, Roozendaal KJ, Eysman L, Wildevuur ORH (1991) Inhibition by dexamethason of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg 102:515-525
14. Kirklin JW, Barratt-Boyes BG (1993) Cardiac Surgery. Wiley, New York, pp 61 -127
15. Lindahl S, Sprlie D, Jprgensen L (1988) Endothelial cells of the cardiac microvasculature during and after cold cardioplegic ischemia. Comparison of endothelial and myocyte damage. Scand J Thorac Cardiovasc Surg 22:257-265
16. Loskutoff DJ, Edgington TS (1977) Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc Natl Acad Sci 74:3903-3907
17. Mankad PS, Chester AH, Yacoub MH (1992) Ischaemic endothelial dysfunction after single or multidose cardioplegia. Eur Heart J 13:976-980
18. Masuda T, Yasue H, Ogawa H, Misumi I, Sakamoto T, Okubu H, Miyao Y, Kato H (1992) Plasma plasminogen activator inhibitor activity and tissue plasminogen activator levels in patients with unstable angina and those with coronary spastic angina. Am Heart J 124:314-319
19. Petaja J, Myllynen P, Myllyla G, Vahtera E (1987) Fibrinolysis after application of a pneumatic tourniquet. Acta Chir Scand 153:647-651
20. Petersen LC, Handest P, Brender J, Selmer J, Jprgensen M, Thor- sen S (1987) A sensitive solid-phase immunosorbant assay for tissue-type plasminogen activator activity in plasma. Thromb Haemost 57:205-211
21. Rashid MA, William-Olsson G (1991) Are leukocytosis and lipid peroxidation involved in ischemic or reperfusion injury in cardiac surgery? J Thorac Cardiovasc Surg 39:193-195
22. Risberg B (1991) Fibrinolysis and its relation to surgical pathophysiology. In: Nilsson TK, Boman K, Jansson JH (eds) Clinical aspects of fibrinolysis. Almquist & Wiksell International, Stockholm, pp 159-179
23. Risberg B, Eriksson E, Bjork S, Hansson GK (1986) Immuno- histochemical localization of plasminogen activators in human saphenous veins. Thromb Res 37:301 -308
24. Romanus M, Risberg B (1978) Fibrinolysis in the ischemic hamster cheek pouch. Thromb Res 12:421 -429
25. Sakata Y, Okada M, Noro A, Matsuda M (1988) Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor on the surface of endothelial cells. J Biol Chem 263: 1960-1969
26. Schneiderman J, Adar R, Savion N (1991) Changes in plasmatic tissue-type plasminogen activator and plasminogen activator inhibitor during acute arterial occlusion associated with severe ischemia. Thromb Res 62:401-408
27. Semb AG, Forsdahl K, Vaage J (1990) Granulocyte and eico- sanoid gradients across the coronary circulation during myocardial reperfusion in cardiac surgery. Eur J Cardio-thorac Surg 4: 543-548
28. Semb AG, Vaage J, Lie M, Sprlie D, Mjps OD (1990) Leucocytes and cardiopulmonary bypass: In vitro production of oxygen free radicals and trapping in the reperfused myocardium. Perfusion 5:169-180
29. Semb AG, Vaage J, Sprlie D, Lie M, Mjps OD (1990) Coronary trapping of a complement activation product (C3a des-Arg) during myocardial reperfusion in open heart surgery. Scand J Thorac Cardiovasc Surg 24:223-227
30. Shatos MA, Doherty JM, Stump DC, Thompson EA, Collen D Oxygen radicals generated during anoxia followed by reoxygenation reduce the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cell culture. J Biol Chem 265:20443-20448
31. Shatos MA, Doherty JM, Orfeo T, Hoak JC, Collen D, Stump DC (1992) Modulation of the fibrinolytic response of cultured human vascular endothelium by extracellularly generated oxygen radicals. J Biol Chem 267:597-601
32. Smith EEJ, Naftel DC, Blackstone EH, Kirklin JW (1987) Mi- crovascular permeability after cardiopulmonary bypass. J Thorac Cardiovasc Surg 94:225-233
33. Southorn PA, Powis G (1988) Free radicals in medicine. I. Chemical nature and biological reactions. Mayo Clin Proc 63: 381-389
34. Tappy L, Hauert J, Bachmann F (1984) Effects of hypoxia and acidosis on vascular plasminogen activator release in the pig ear perfusion system. Thromb Res 33:117-124
35. Thompson JA, Hess ML (1986) The oxygen free radical system: A fundamental mechanism in the production of myocardial necrosis. Prog Cardiovasc Dis 38:449-462
36. Tsao PS, Aoki N, Lefer DJ, Johnson G III, Lefer AM (1990) Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 82:1402-1412
37. Vaage J (1990) Reperfusion damage of the myocardium. In: Thygesen K, Kjekshus J (eds) Myocardial ischemia. Blackwell, London, pp 84-93
38. Vaage J, Valen G (1991) Could treatment with scavengers of oxygen free radicals minimize complications in cardiac surgery? Klin Wochenschr 69:1066-1072
39. Valen G, Blomback M, Sellei P, Lindblom D, Vaage J (1994) Release of von Willebrand Factor by cardiopulmonary bypass, but not by cardioplegia in open heart surgery. Thromb Res: 73: 21-29
40. Valen G, Erikson E, Risberg B, Vaage J (1993) Reactive oxygen intermediates and ischemia-reperfusion injury release tissue plasminogen activator from isolated rat hearts. Thromb Res 71:113-121
41. Valen G, Kaszaki J, Nagy S, Vaage J (1994) Open heart surgery increases histamine in arterial and coronary sinus blood. Agents Actions 40: In press
42. Zilla P, Oppell U von, Deutsch M (1993) The endothelium: A key to the future. J Cardiac Surg 8:32-60